After pancreatectomy for cancer, half still have severe gut symptoms at a year

Design

Prospective nationwide longitudinal cohort

Population

1,009 patients undergoing pancreatectomy for pancreatic cancer in the Netherlands

Primary outcome

Gastrointestinal symptoms and health-related quality of life to 12 months

Effect

Severe symptoms 61% before surgery, 52% at 9–12 months

The Dutch GO-PANC study followed 1,009 patients through pancreatectomy for pancreatic cancer, collecting 2,995 questionnaires before surgery and at three-monthly intervals to a year.

Before surgery 95% already had gastrointestinal symptoms, commonly flatulence, dry mouth, taste change and altered bowel habit. Symptom scores peaked in the first three months and generally returned to baseline or below by 9 to 12 months. Severe symptoms affected 61% before surgery and 52% at a year. Having two or more severe symptoms was linked to clinically meaningful falls in quality of life.

Much of this burden — steatorrhoea, bloating, altered bowel habit — overlaps with exocrine insufficiency, which is treatable. The study is a reminder to ask, and to treat, rather than assume symptoms are an inevitable cost of the operation.

• Ask about gut symptoms before pancreatectomy; nearly all patients already have them.
• Warn patients that symptoms usually peak in the first three months and then ease.
• Screen for and treat pancreatic exocrine insufficiency in patients with persistent bloating, flatulence or altered stools.
• Patients with two or more severe symptoms have markedly worse quality of life and merit dietetic review.

Why it matters

Half of survivors carry a severe symptom burden that routine follow-up focused on recurrence can miss.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.